Outlook Therapeutics Inc (OTLK) USD0.01

Sell:$0.27Buy:$0.27Price decreased$0.00 (0.95%)

Prices delayed by at least 15 minutes
Sell:$0.27
Buy:$0.27
Change:Price decreased$0.00 (0.95%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.27
Buy:$0.27
Change:Price decreased$0.00 (0.95%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$0.29
Previous close$0.27
Market cap$26.47m
P/E ratio-99999.99
Volume2,310,399
Dividend yield0.00%
EMS-

Company information

Outlook Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing ONS-5010/LYTENAVA (bevacizumab-gamma), an ophthalmic formulation of bevacizumab for use in retinal ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue104.61m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.